Cerebral hypoxia: some new approaches and unanswered questions.
Choi
D W
DW
Department of Neurology, Stanford University Medical Center, California 94305.
D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D001927:Brain Diseases / Q000209:etiology / Q000473:pathology / Q000628:therapy; D002470:Cell Survival; D002560:Cerebrovascular Circulation; D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates / Q000502:physiology; D018698:Glutamic Acid; D006801:Humans; D000860:Hypoxia / Q000209:etiology / Q000473:pathology / Q000628:therapy; D016202:N-Methylaspartate; D009457:Neuroglia / Q000473:pathology; D009474:Neurons / Q000473:pathology; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000502:physiology
D018691:Excitatory Amino Acid Antagonists; D005971:Glutamates; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter; D001224:Aspartic Acid; D018698:Glutamic Acid; D016202:N-Methylaspartate